Compartment modeling

Advanced Drug Delivery Reviews

Volumn 48, Issue 2-3, 2001, Pages 249-264

  Holz, Martin ^a   Fahr, Alfred ^b  

^a Philipps Universität Marburg ^*  (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL;

COMPARTMENT MODEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG TRANSPORT; EXPERIMENTAL MODEL; LINEAR SYSTEM; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC CIRCULATION; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; DRUG DELIVERY SYSTEMS; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS;

EID: 0035844739     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00118-1     Document Type: Review

References (57)

1. Box G., Draper N. Evolutionary Operation: A Statistical Method For Process Improvement. 1969;John Wiley and Sons.
2. Teorell T. Kinetics of distribution of substances administered to the body. Arch. Intern. Pharmacodyn. 57:1937;205-240.
3. Balant L.P., Gex F.M. Physiological pharmacokinetic modelling. Free Radic. Biol. Med. 8:1990;471-485.
4. Roth W.L., Freeman R.A., Wilson A.G. A physiologically based model for gastrointestinal absorption and excretion of chemicals carried by lipids. Risk Anal. 13:1993;531-543.
5. Andersen M.E. Physiological modelling of organic compounds. Ann. Occup. Hyg. 35:1991;309-321.
6. Bailer A.J., Dankovic D.A. An introduction to the use of physiologically based pharmacokinetic models in risk assessment. J. Pharmacokinet. Biopharm. 25:1997;313-348.
7. Aronsson G., Kellogg R.B. On a Differential equation arising from compartment analysis. Math. Biosci. 38:1978;113-122.
8. Colburn W.A. Controversy III: to model or not to model. J. Clin. Pharmacol. 28:1988;879-888.
9. Kotzerke J., Burchert W., Wiese H., von Smekal U., Hundeshagen H. Limitations of clearance determination using the single sample distribution volume method. An error analysis on the basis of compartment models. Arzneimittelforschung. 42:1992;350-352.
10. Sedman A.J., Wagner J.G. Quantitative pooling of Michaelis-Menten equations with parallel metabolite formation paths. J. Pharmacokin. Biopharm. 2:1974;149-160.
11. Spears G., Sneyd J.G.T., Loten E.G. A method of deriving kinetic constants for two enzymes acting on the same substrate. Biochem. J. 125:1971;1149-1151.
12. Neal J.L. Analysis of Michaelis-Menten kinetics for two independent saturable membrane transport functions. J. Theor. Biol. 35:1972;113-118.
13. Gillespie W.R. Generalized pharmacokinetic modeling for drugs with nonlinear binding: I. Theoretical framework. J. Pharmacokinet. Biopharm. 21:1993;99-124.
14. Levitt M.D., Levitt D.G. Use of a two-compartment model to assess the pharmacokinetics of human ethanol metabolism. Pharm. Res. 16:1999;302-308.
15. Shoaf S.E. Pharmacokinetics of intravenous alcohol: two compartment, dual Michaelis-Menten elimination. Alcohol Clin. Exp. Res. 24:2000;424-425.
16. Piotrovskij V., Van Peer A. A model with separate hepato-portal compartment (`first-pass' model): fitting to plasma concentration-time profiles in humans. J. Pharm. Sci. 87:1998;470-481.
17. Chappell M.J. Structural identifiability and indistinguishability of certain two-compartment models incorporating nonlinear efflux from the peripheral compartment. Am. J. Physiol. 277:1999;E481-488.
18. Derendorf H., Meibohm B. Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives. Pharm. Res. 13:1999;176-185.
19. Hu C., Lovejoy W.S., Shafer S.L. Comparison of some control strategies for three-compartment PK/PD models. J. Anim. Sci. 73:1995;177-190.
20. Jacobs J.R., Williams E.A. Algorithm to control `effect compartment' drug concentrations in pharmacokinetic model-driven drug delivery. J. Pharmacokinet. Biopharm. 21:1993;689-734.
21. Nerella N.G., Block L.H., Noonan P.K. The impact of lag time on the estimation of pharmacokinetic parameters. I. One-compartment open model. J. Pharm. Res. 10:1993;1031-1036.
22. Nerella N.G., Block L.H., Noonan P.K. The impact of lag time on the estimation of pharmacokinetic parameters. I. One-compartment open model. J. Pharm. Pharmacol. 45:1993;934-936.
23. Nerella N.G., Block L.H., Noonan P.K. The impact of lag time on the estimation of pharmacokinetic parameters. I. One-compartment open model. Int. J. Biomed. Comput. 32:1993;111-120.
24. Cherruault Y., Sarin V.B. A three compartment open model with two time lags. J. Pharm. Sci. 81:1992;863-865.
25. Cherruault Y., Sarin V.B. A three compartment open model with two time lags. Eur. J. Drug Metab. Pharmacokinet. 18:1993;333-338.
26. Cherruault Y., Sarin V.B. A four compartment open model with first-order absorption. Int. J. Biomed. Comput. 32:1993;269-277.
27. Cherruault Y., Sarin V.B. A three compartment open model with two time lags. J. Pharmacokinet. Biopharm. 22:1994;103-128.
28. Merino J.A., De Biasi J., Plusquellec Y., Houin G. Local identifiability for two and three-compartment pharmacokinetic models with time-lags. Pharmacol. Res. 37:1998;157-163.
29. Merino J.A., De Biasi J., Plusquellec Y., Houin G. Local identifiability for two and three-compartment pharmacokinetic models with time-lags. J. Pharmacokinet. Biopharm. 22:1994;525-550.
30. Purves R.D. Anomalous parameter estimates in the one-compartment model with first-order absorption. Int. J. Biomed. Comput. 32:1993;111-120.
31. Garrett E.R. The Bateman function revisited: a critical reevaluation of the quantitative expressions to characterize concentrations in the one compartment body model as a function of time with first-order invasion and first-order elimination. Med. Eng. Phys. 20:1998;261-268.
32. Garrett E.R. Simplified methods for the evaluation of the parameters of the time course of plasma concentration in the one-compartment body model with first-order invasion and first-order drug elimination including methods for ascertaining when such rate constants are equal. J. Pharmacokin. Biopharmaceut. 21:1993;689-734.
33. Garrett E.R. Simplified methods for the evaluation of the parameters of the time course of plasma concentration in the one-compartment body model with first-order invasion and first-order drug elimination including methods for ascertaining when such rate constants are equal. Pharm. Res. 10:1993;1031-1036.
34. Garrett E.R. Simplified methods for the evaluation of the parameters of the time course of plasma concentration in the one-compartment body model with first-order invasion and first-order drug elimination including methods for ascertaining when such rate constants are equal. Eur. Respir. J. 6:1993;785-790.
35. Cobelli C., Jj D. Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. Am. J. Physiol. 239:1980;R7-R24.
36. Wagner J.G. Do you need a pharmacokinetic model, and, if so, which one. J. Pharmacokinet. Biopharmaceut. 3:1975;457-478.
37. Wagner J.G. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to data. J. Pharmacokin. Biopharmaceut. 4:1976;443-467.
38. Benet L.Z. General Treatment of Linear Mammilary Models with Elimination from Any Compartment as Used in Pharmacokinetics. J. Pharm. Sci. 61:1972;535-541.
39. Charkes N.D., Siegel J.A. An analytical solution set for a four-compartment mixed mammillary/catenary model. Biosystems. 36:1995;121-133.
40. Charkes N.D., Siegel J.A. An analytical solution set for a four-compartment mixed mammillary/catenary model. Pharmacol. Res. 41:2000;445-453.
41. Varón R., García Meseguer M.J., Havsteen B. General linear compartment model with zero input: II. The computerized derivation of the kinetic equations. Biosystems. 36:1995;145-156.
42. Varón R., García Meseguer M.J., García Cánovas F., Havsteen B. General linear compartment model with zero input: I. Kinetic equations. Biosystems. 36:1995;135-144.
43. Varón R., García Meseguer M.J., Valero E., García Moreno M., García Cánovas F. General linear compartment model with zero input: III. First passage residence time of enzyme systems. Nucl. Med. Commun. 20:1999;925-932.
44. Doetsch G. Laplace Transformationen. 1981;Oldenbourg Inc, Munich and Vienna.
45. I. Micromath, Micromath Scientist (1995).
46. Heinzel G., Woloszcack R., Thomann P. TopFit 2.0 Pharmacokinetic and Pharmacodynamic Data Analysis System For the PC. 1993;Gustav Fischer Verlag, Stuttgart, Jena, New York.
47. Weiner D.L. WINNONLIN. 1996;Pharsight Corporation, Montain View, CA.
48. Gabrielsson J.L., Weiner D.L. Methodology for pharmacokinetic/pharmacodynamic data analysis. Pharm. Sci. Technol. 2:(6):1999;244-252.
49. Garcia F., Arruda-Neto J.D., Manso M.V., Helene O.M., Vanin V.R., Rodriguez O., Mesa J., Likhachev V.P., Filho J.W., Deppman A., Perez G., Guzman F., de Camargo S.P. A new statistical method for transfer coefficient calculations in the framework of the general multiple-compartment model of transport for radionuclides in biological systems. J. Pharmacokinet. Biopharm. 24:1996;79-101.
50. Piessens R., Huysmans R. Automatic numerical inversion of the Laplace transform and applications. ACM Trans. Math. Softw. 10:1984;348-353.
51. Kuhnz W., Gansau C., Mahler M. Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17 β-Estradiol. Arzneim-Forsch/Drug Res. 43:1993;966-973.
52. Reddy M.B., McCarley K.D., Bunge A.L. Physiologically relevant one-compartment pharmacokinetic models for skin. 2. Comparison of models when combined with a systemic pharmacokinetic model. J. Appl. Physiol. 85:1998;238-245.
53. Reddy M.B., McCarley K.D., Bunge A.L. Physiologically relevant one-compartment pharmacokinetic models for skin. 2. Comparison of models when combined with a systemic pharmacokinetic model. Eur. J. Nucl. Med. 19:1992;19-24.
54. McCarley K.D., Bunge A.L. Physiologically relevant one-compartment pharmacokinetic models for skin. 1. Development of models. Am. J. Physiol. 276:1999;E1171-E1193. [published erratum appears in J. Pharm. Sci. 1998 Oct;87(10):1264].
55. McCarley K.D., Bunge A.L. Physiologically relevant one-compartment pharmacokinetic models for skin. 1. Development of models. J. Pharm. Sci. 87:1998;482-490.
56. Kubota K., Maibach H.I. A compartment model for percutaneous absorption: compatibility of lag time and steady-state flux with diffusion model. Am. J. Ther. 4:1997;92-98.
57. Kubota K., Maibach H.I. A compartment model for percutaneous absorption: compatibility of lag time and steady-state flux with diffusion model. Eur. J. Nucl. Med. 19:1992;1023-1031.